There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
It has been debated whether single- vs dual-hormone artificial pancreas systems are better for patients with type 2 diabetes mellitus. Tell us what you think via our latest poll.
The USPSTF released a recommendation statement regarding the benefit of screening children and adolescents for type 2 diabetes. Take our poll to let us know what you think!
It has been debated whether single- vs dual-hormone artificial pancreas systems are better for patients with type 2 diabetes mellitus. Tell us what you think via our latest poll.
